Shanghai Pharma has signed a new 20-year collaboration with Milan’s Bracco Imaging to develop Bracco’s microbubbles technology as an ultrasound contrast agent to image tumor angiogenesis. Microbubbles are already used to image cardiac cavities, large vessels and tissue vascularity. Since 2001, Bracco has collaborated with Shanghai Sine, a subsidiary of Shanghai Pharma via a JV. The new collaboration will support an innovative Shanghai Pharma immuno-oncology candidate aimed at pancreatic cancer.
Source: China Biotoday
